223 related articles for article (PubMed ID: 22748832)
1. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
[TBL] [Abstract][Full Text] [Related]
2. [Neurotrophic factors: basis for their clinical application].
Morís G; Vega JA
Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnological applications for the treatment of neurodegenerative disorders.
Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
[TBL] [Abstract][Full Text] [Related]
6. Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Ann N Y Acad Sci; 2007 Dec; 1122():155-68. PubMed ID: 18077571
[TBL] [Abstract][Full Text] [Related]
7. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
Popovic N; Brundin P
Int J Pharm; 2006 May; 314(2):120-6. PubMed ID: 16529886
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration.
Skaper SD; Walsh FS
Mol Cell Neurosci; 1998 Nov; 12(4-5):179-93. PubMed ID: 9828084
[TBL] [Abstract][Full Text] [Related]
10. Growth factor treatment of neurodegenerative disorders: new developments pave the way for clinical success.
Rosenblad C
IDrugs; 2004 Mar; 7(3):243-8. PubMed ID: 15011099
[TBL] [Abstract][Full Text] [Related]
11. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
Bartus RT; Johnson EM
Neurobiol Dis; 2017 Jan; 97(Pt B):156-168. PubMed ID: 27063798
[TBL] [Abstract][Full Text] [Related]
12. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
Kordower JH
Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104
[TBL] [Abstract][Full Text] [Related]
13. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
Bartus RT; Johnson EM
Neurobiol Dis; 2017 Jan; 97(Pt B):169-178. PubMed ID: 27063797
[TBL] [Abstract][Full Text] [Related]
14. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
Kordower JH; Isacson O; Emerich DF
Exp Neurol; 1999 Sep; 159(1):4-20. PubMed ID: 10486171
[TBL] [Abstract][Full Text] [Related]
15. Repairing the parkinsonian brain with neurotrophic factors.
Aron L; Klein R
Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
17. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.
Youdim MB; Buccafusco JJ
Trends Pharmacol Sci; 2005 Jan; 26(1):27-35. PubMed ID: 15629202
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol: an antitumor drug with potential application in the treatment of neurodegenerative diseases.
Pallàs M; Verdaguer E; Jordà EG; Jiménez A; Canudas AM; Camins A
Med Hypotheses; 2005; 64(1):120-3. PubMed ID: 15533627
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders.
Sharma HS; Muresanu DF; Sharma A
Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic factor therapy for Parkinson's disease.
Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
